• Demethyleneberberine and Neurodegenerative Disease

  2026-09-08

  The 2022 review proposes Demethyleneberberine (DMB) as a neuroprotective candidate by connecting antioxidant, mitochondrial, and anti-inflammatory activity with NF-κB, MAPK, and AMPK signaling. Its main value is mechanistic integration rather than clinical proof, giving researchers a framework for evaluating DMB in neuroinflammation, oxidative stress, and disease-specific cellular models.

• Roscovitine: Designing Better CDK Assays

  2026-09-08

  Roscovitine (Seliciclib) is more than a CDK inhibitor: it is a useful calibration tool for connecting biochemical potency, reversible cell-cycle phenotypes, and assay design. This guide shows how to interpret its selectivity and apply it rigorously in cancer biology research.

• Ouabain Workflows for Na+/K+-ATPase Assays

  2026-09-07

  Build mechanism-focused Ouabain experiments that connect sodium-pump inhibition with calcium handling, viability, and cardiac physiology. This guide combines a practical Na+/K+-ATPase inhibition assay workflow with assay-design lessons from cancer drug-response research, while separating product specifications from starting recommendations.

• Stable Yeast Expression of Exendin-4: Study Review

  2026-09-07

  Balius et al. developed recombinant expression models for Exendin-4, also known as Exenatide, in Escherichia coli and Saccharomyces cerevisiae. Chromosomally integrated yeast produced immunoreactive Exendin-4 at the expected size, providing an early synthetic-biology foundation for more accessible production while leaving bioactivity, purification, oral delivery, and therapeutic efficacy unresolved.

• Angiotensin 1/2 (1-6): An Assay-Design Guide

  2026-09-05

  Angiotensin 1/2 (1-6) is a defined Asp-Arg-Val-Tyr-Ile-His hexapeptide for resolving renin-angiotensin system biology. This guide goes beyond product description to explain fragment identity, assay controls, and the evidentiary boundaries of cardiovascular, renal, and spike-receptor research.

• Dextrose in Hypoxic Tumor Immunometabolism

  2026-09-04

  Dextrose (D-glucose) is more than a routine media ingredient: it is a controllable metabolic input for investigating how hypoxia, nutrient competition, and immune dysfunction interact in tumors. This thought-leadership article connects mechanistic findings with experimental design, product selection, and translational decision-making while defining the limits of glucose supplementation models.

• Müller Cell PEDF in Angiopoietin Retinal Survival

  2026-09-04

  The 2026 study by Younis and colleagues identifies Müller cell-derived pigment epithelium-derived factor (PEDF) as a key intermediary connecting angiopoietin signaling with retinal neuron survival. Its co-culture, hypoxia, gene-silencing, and phospho-signaling experiments distinguish the opposing effects of Ang-1 and Ang-2 and provide a framework for mechanistic retinal neurovascular assays.

• Temafloxacin: From PK to Assay Design

  2026-09-03

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent whose pharmacokinetic behavior can guide more interpretable antimicrobial assays. This article connects exposure, tissue distribution, renal clearance, and concentration selection to practical research decisions.

• Canagliflozin Reshapes Renal Mitochondria in Mice

  2026-09-03

  The reference study shows that canagliflozin improves proximal tubular mitochondrial architecture and bioenergetics in hypertensive–diabetic mice, with a stronger functional response in males. Its main contribution is to connect SGLT2 inhibition with renal mitochondrial remodeling and albuminuria improvement beyond glucose lowering alone.

• Docetaxel Workflows for Chemoresistance Research

  2026-09-02

  Build more informative Docetaxel assays by pairing microtubule-driven cytotoxicity with cell-cycle, apoptosis, and multidrug-resistance readouts. A renal cell carcinoma study provides a practical framework for testing how SMYD2 and miR-125b biology may alter response to Taxotere-like treatment.

• Surrogate BBB Model Improves CNS Permeability Prediction

  2026-09-02

  Hu and colleagues developed a high-throughput Transwell blood-brain barrier surrogate using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, combining permeability measurements with P-glycoprotein efflux analysis and correction for lysosomal trapping. Across 41 compounds, the model correlated MDR1-derived permeability with unbound brain distribution and improved interpretation of low-recovery compounds, supporting earlier CNS candidate prioritization.

• Metformin Attenuates Vocal Fold Fibrosis via AMPK

  2026-09-01

  The reference study combines a rabbit vocal fold injury model with TGF-β1-stimulated fibroblasts to show that metformin reduces collagen deposition and fibrotic marker expression while activating AMPK. Its main contribution is a preclinical mechanistic framework linking AMPK signaling to structural preservation of the vocal fold lamina, although clinical efficacy and dose translation remain unestablished.

• Demethyleneberberine: From Metabolite to Model Design

  2026-09-01

  Demethyleneberberine is a multitarget natural alkaloid with applications spanning inflammation, neuroprotection, liver injury, and NSCLC research. This evidence-led guide shows how to translate its mechanisms into better assay selection, controls, dosing, and interpretation.

• AhR-Mediated MEHP Toxicity in Mouse Ovarian Follicles

  2026-08-31

  This study identifies the aryl hydrocarbon receptor as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological AhR blockade partially restored follicle growth and estrogen-related endpoints, linking phthalate exposure to altered xenobiotic signaling, steroidogenesis, and reproductive physiology.

• SIRT1–PGC-1α–TFAM Signaling in Prion-Stressed N2a Cells

  2026-08-31

  Zhao et al. show that prion protein fragment 106–126 damages mitochondria in N2a cells partly by suppressing SIRT1-dependent mitochondrial biogenesis. The study identifies the SIRT1–PGC-1α–TFAM axis as a mechanistic link between mitochondrial quality control and neuronal apoptosis, with resveratrol providing pharmacological support for this pathway.

8136 records 1/543 page Next 12345 下5页 Last page